Ramatsoma Hlologelo, Patrick Sean Mark
School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Front Neurol. 2022 Mar 16;13:857600. doi: 10.3389/fneur.2022.857600. eCollection 2022.
Hypertension is one of the leading causes of morbidity and mortality worldwide, and has been associated with target organ damage. Effects of hypertension on the auditory system are varied and requires further investigation. This study aimed to investigate the association between hypertension and auditory deficits (hearing loss and tinnitus).
This study employed a cross-sectional study including 106 (54.7% female) hypertensive adults aged 18-55 years, and 92 (52.2% female) non-hypertensive sex- and age-matched adults residing in South Africa. A data extraction sheet was used to obtain hypertension information from participants' medical files, and to subjectively obtain tinnitus status and characteristics among participants. Participants' hearing sensitivity-including extended high frequencies (EHF)-were measured using a diagnostic audiometer. The χ2 test determined the difference in auditory deficit prevalence between the study groups. Logistic regression was used to identify predictor variables associated with auditory deficits in the hypertensive group.
A hearing loss prevalence of 37.4% among hypertensive adults compared to 14.1% among the non-hypertensive group ( = 0.000, χ2 = 14.00) was found. The EHF pure-tone average among the hypertensive group was 44.1 ± 19.2 dB HL, and 20.0 ± 18.3 dB HL among the control group. Bilateral mild sensorineural hearing loss was the most common type of hearing loss among hypertensive adults. A higher prevalence of tinnitus (41.5%) was found in the hypertensive group compared to the control group (22.8%) ( = 0.008, χ2 = 7.09). In this study, 30.3% of hypertensive adults had tinnitus without hearing loss compared to 17.7% non-hypertensive adults. Factors associated with hearing loss included being between 50 and 55 years [adjusted Odds Ratio (AOR) = 3.35; 95% Confidence Interval (CI): 1.32-8.50; = 0.011], having grade 2 hypertension (AOR = 4.18; 95% CI: 1.02-17.10; = 0.048), and being on antihypertensive medication (AOR = 3.18; 95% CI: 1.02-9.87; = 0.045). Tinnitus was associated with grade 3 hypertension (AOR = 3.90; 95% CI: 1.12-12.64; = 0.033).
Our study showed that hypertensive adults had a higher proportion of hearing loss and tinnitus compared to non-hypertensive adults. Findings suggest an association between hypertension and auditory deficits, demonstrating a need for integration of hearing healthcare services for hypertension management.
高血压是全球发病和死亡的主要原因之一,并且与靶器官损害相关。高血压对听觉系统的影响是多样的,需要进一步研究。本研究旨在调查高血压与听觉缺陷(听力损失和耳鸣)之间的关联。
本研究采用横断面研究,纳入了106名年龄在18 - 55岁的高血压成年患者(女性占54.7%),以及92名居住在南非的年龄和性别匹配的非高血压成年患者(女性占52.2%)。使用数据提取表从参与者的医疗档案中获取高血压信息,并主观获取参与者的耳鸣状态和特征。使用诊断听力计测量参与者的听力敏感度,包括扩展高频(EHF)。χ2检验确定研究组之间听觉缺陷患病率的差异。逻辑回归用于确定高血压组中与听觉缺陷相关的预测变量。
发现高血压成年患者的听力损失患病率为37.4%,而非高血压组为14.1%(P = 0.000,χ2 = 14.00)。高血压组的EHF纯音平均听阈为44.1±19.2 dB HL,对照组为20.0±18.3 dB HL。双侧轻度感音神经性听力损失是高血压成年患者中最常见的听力损失类型。与对照组(22.8%)相比,高血压组的耳鸣患病率更高(41.5%)(P = 0.008,χ2 = 7.09)。在本研究中,30.3%的高血压成年患者有耳鸣但无听力损失,而非高血压成年患者为17.7%。与听力损失相关的因素包括年龄在50至55岁之间[调整后比值比(AOR)= 3.35;95%置信区间(CI):1.32 - 8.50;P = 0.011]、患有2级高血压(AOR = 4.18;95% CI:1.02 - 17.10;P = 0.048)以及正在服用抗高血压药物(AOR = 3.18;95% CI:1.02 - 9.87;P = 0.045)。耳鸣与3级高血压相关(AOR = 3.90;95% CI:1.12 - 12.64;P = 0.033)。
我们的研究表明,与非高血压成年患者相比,高血压成年患者的听力损失和耳鸣比例更高。研究结果表明高血压与听觉缺陷之间存在关联,这表明在高血压管理中需要整合听力保健服务。